Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia
- PMID: 30740418
- PMCID: PMC6330631
- DOI: 10.21037/atm.2018.11.23
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia
Conflict of interest statement
Conflicts of Interest: P Lucidi has received travel grants for scientific meetings from Sanofi and Menarini; F Porcellati has received honoraria for lectures and consultations from Sanofi, Eli Lilly, Astra Zeneca and Medtronic; GB Bolli has received honoraria for lectures and consultations from Sanofi and Menarini; CG Fanelli has received honoraria for lecturing and consultations from Sanofi and travel grants from Menarini.
Comment on
-
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.Lancet. 2018 Apr 7;391(10128):1367-1377. doi: 10.1016/S0140-6736(18)30297-6. Epub 2018 Feb 16. Lancet. 2018. PMID: 29459019 Clinical Trial.
References
-
- Fanelli CG, Lucidi P, Bolli GB, et al. Endocrinology. In: Bonora E, DeFronzo R. editors. Diabetes Complications, Comorbidities and Related Disorders. Cham: Springer, 2018:1-38.
-
- Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-9. 10.2337/diab.42.11.1683 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources